Bayer | BAYN - Net Income



Bayer reported EUR-199000000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Air Liquide EUR 1.8B 175.9M Jun/2025
Akzo Nobel EUR 124M 17M Jun/2025
Alcon AG USD 176M 174M Jun/2025
Amarin USD -15697000 32.92M Mar/2025
Arkema EUR 47M 2M Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
BASF EUR 79M 729M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Beiersdorf EUR 552M 222M Jun/2025
Corteva USD 1.31B 662M Jun/2025
Covestro EUR -59000000 101M Jun/2025
Essilor EUR 1.39B 890M Jun/2025
Fresenius EUR 330M 101M Jun/2025
Fresenius Medical Care EUR 225M 74M Jun/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 1.44B 181M Jun/2025
GRIFOLS EUR 117.06M 57.34M Jun/2025
Henkel EUR 1.11B 132M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Johnson Matthey GBP -111000000 595M Mar/2025
Linde USD 1.77B 41M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 652M 83M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Nutrien USD 1.22B 1.21B Jun/2025
Philips EUR 240M 165M Jun/2025
PPG Industries USD 450M 77M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
SAP EUR 1.75B 31M Jun/2025
Solvay EUR 9M 72M Jun/2025
UCB EUR 857M 649M Dec/2024
Umicore EUR 136.7M 140.65M Jun/2025
Vinci EUR 1.9B 971M Jun/2025